Parmax Pharma Ltd Q4 FY2023-2024 Results: Summary
Revenue | ₹4.27Cr |
Net Profits | ₹-1.45Cr |
Net Profit Margins | -33.96% |
Highlights
Revenue:
Parmax Pharma Ltd’s revenue fell -33.28% since last year same period to ₹4.27Cr in the Q4 2023-2024. On a quarterly growth basis, Parmax Pharma Ltd has generated 218.66% jump in its revenue since last 3-months.
Net Profits:
Parmax Pharma Ltd’s net profit fell -952.94% since last year same period to ₹-1.45Cr in the Q4 2023-2024. On a quarterly growth basis, Parmax Pharma Ltd has generated 17.14% jump in its net profits since last 3-months.
Net Profit Margins:
Parmax Pharma Ltd’s net profit margin fell -1378.41% since last year same period to -33.96% in the Q4 2023-2024. On a quarterly growth basis, Parmax Pharma Ltd has generated 74% jump in its net profit margins since last 3-months.
